Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

This study has been completed.

Study NCT00073502 Information provided by OSI Pharmaceuticals

First Received: November 21, 2003 Last Updated: February 17, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2003
Estimated Primary Completion Date:	No date given